161 related articles for article (PubMed ID: 37409312)
1. Characteristics and treatment pathways in pediatric and adult hidradenitis suppurativa: An examination using real world data.
Hardin J; Makadia R; Black S; Lara-Corrales I; Diaz LZ; Kirby JS; DeKlotz CMC
JAAD Int; 2023 Sep; 12():124-132. PubMed ID: 37409312
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
[TBL] [Abstract][Full Text] [Related]
3. Phenotype Algorithms to Identify Hidradenitis Suppurativa Using Real-World Data: Development and Validation Study.
Hardin J; Murray G; Swerdel J
JMIR Dermatol; 2022 Nov; 5(4):e38783. PubMed ID: 37632892
[TBL] [Abstract][Full Text] [Related]
4. Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.
Marvel J; Vlahiotis A; Sainski-Nguyen A; Willson T; Kimball A
BMJ Open; 2019 Sep; 9(9):e030579. PubMed ID: 31575575
[TBL] [Abstract][Full Text] [Related]
5. Real-World Findings on the Characteristics and Treatment Exposures of Patients with Hidradenitis Suppurativa from US Claims Data.
Garg A; Naik HB; Alavi A; Hazen P; Hsiao JL; Shi VY; Weisman J; Tran T; Rudnik J; Jedrzejczyk A; Pansar I; Kimball AB
Dermatol Ther (Heidelb); 2023 Feb; 13(2):581-594. PubMed ID: 36585607
[TBL] [Abstract][Full Text] [Related]
6. Pediatric hidradenitis suppurativa: Describing care patterns in the emergency department.
Lambert RA; Stein SL
Pediatr Dermatol; 2023; 40(3):434-439. PubMed ID: 36856161
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
Peterson GC; Preston A; Frieder J; Wang X; Paek SY
Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
[TBL] [Abstract][Full Text] [Related]
8. Differences Between Children and Adults With Hidradenitis Suppurativa.
Hallock KK; Mizerak MR; Dempsey A; Maczuga S; Kirby JS
JAMA Dermatol; 2021 Sep; 157(9):1095-1101. PubMed ID: 34379074
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of topical resorcinol 15% versus topical clindamycin 1% in the management of mild-to-moderate hidradenitis suppurativa: A retrospective study.
Molinelli E; Brisigotti V; Simonetti O; Sapigni C; D'Agostino GM; Rizzetto G; Giacchetti A; Offidani A
Dermatol Ther; 2022 Jun; 35(6):e15439. PubMed ID: 35278025
[TBL] [Abstract][Full Text] [Related]
10. Hidradenitis suppurativa in the pediatric population.
Liy-Wong C; Pope E; Lara-Corrales I
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S36-41. PubMed ID: 26470613
[TBL] [Abstract][Full Text] [Related]
11. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
[TBL] [Abstract][Full Text] [Related]
12. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional study of pediatric hidradenitis suppurativa and the value of the International Hidradenitis Suppurativa Severity Score System (IHS4) as a pediatric clinical trial inclusion criteria.
Bui H; Sayed C
Pediatr Dermatol; 2022 Sep; 39(5):689-694. PubMed ID: 35766518
[TBL] [Abstract][Full Text] [Related]
14. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.
Khalsa A; Liu G; Kirby JS
J Am Acad Dermatol; 2015 Oct; 73(4):609-14. PubMed ID: 26190241
[TBL] [Abstract][Full Text] [Related]
15. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa.
Gulliver W; Zouboulis CC; Prens E; Jemec GB; Tzellos T
Rev Endocr Metab Disord; 2016 Sep; 17(3):343-351. PubMed ID: 26831295
[TBL] [Abstract][Full Text] [Related]
17. A Canadian Population-Based Cohort to the Study Cost and Burden of Surgically Resected Hidradenitis Suppurativa.
Mehdizadeh A; Rosella L; Alavi A; Sibbald G; Farzanfar D; Hazrati A; Vernich L; Laporte A; Hu H; Bashash M
J Cutan Med Surg; 2018; 22(3):312-317. PubMed ID: 29528753
[TBL] [Abstract][Full Text] [Related]
18. LAight® Therapy Significantly Enhances Treatment Efficacy of 16 Weeks of Topical Clindamycin Solution in Hurley I and II Hidradenitis Suppurativa: Results from Period A of RELIEVE, a Multicenter Randomized, Controlled Trial.
Schultheis M; Staubach P; Nikolakis G; Grabbe S; Ruckes C; von Stebut E; Kirschner U; Matusiak Ł; Szepietowski JC
Dermatology; 2022; 238(3):476-486. PubMed ID: 34535610
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic delay in Hidradenitis suppurativa investigated using data from social media and from statutory health insurances.
Kirschner U; Kahn M; Papukchieva S; Stosio K; Keis A; Biermann MHC; Häusser-Fruh G; Sturm L; Eberl M; Friedrich B; Kurzen H
J Dtsch Dermatol Ges; 2024 Jun; 22(6):803-809. PubMed ID: 38769083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
